Analyst Price Target is $15.83
▲ +385.69% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for AbCellera Biologics in the last 3 months. The average price target is $15.83, with a high forecast of $24.00 and a low forecast of $5.00. The average price target represents a 385.69% upside from the last price of $3.26.
Current Consensus is
Buy
The current consensus among 7 investment analysts is to buy stock in AbCellera Biologics. This Buy consensus rating has held steady for over two years.